Nanobac Pharmaceuticals, Incorporated (NNBP) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Nanobac Pharmaceuticals, Incorporated's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
0.00
Strong
WeakModerateStrong
P/B Ratio
0.00
Strong
WeakModerateStrong
Earnings Yield
0.00%
Yield Trap
WeakModerateStrong
Profitability Health
2007Return on Equity
278.38%
Strong
WeakModerateStrong
Operating Margin
27891.78%
Strong
WeakModerateStrong
Net Profit Margin
-37319.74%
Weak
WeakModerateStrong
Growth Indicators
2007Revenue Growth
-92.17%
Weak
WeakModerateStrong
Net Income Growth
-32.23%
Weak
WeakModerateStrong
EPS Growth
100.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2007Current Ratio
0.00
Weak
WeakModerateStrong
Quick Ratio
0.00
Weak
WeakModerateStrong
Asset Turnover
0.00x
Weak
WeakModerateStrong
Inventory Turnover
1.41x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-
No data
EV / Free Cash Flow
-4.51x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.69x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-1.338
Weak
WeakModerateStrong
Return on Invested Capital
106.93%
Strong
WeakModerateStrong
Cash Conversion Cycle
-26811.90 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for NNBP.
View Financial Statements